Holen Sie sich die Stockscreener-App
8.75
12.15%
-1.21
Handel nachbörslich:
8.65
-0.10
-1.14%
Finanzdaten der Candel Therapeutics Inc-Aktie (CADL)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | 0.102 |
Operating Expenses
|
23.42%
7.902
|
10.32 | 8.861 | 9.579 | 9.633 |
| Interest Income/Expense |
4.01%
0.646
|
0.673 | 0.669 | 0.644 | 0.609 |
| Operating Income/Loss |
23.42%
-7.902
|
-10.32 | -8.861 | -9.579 | -9.633 |
| Nonoperating Income/Loss |
58.94%
-0.319
|
-0.777 | 0.426 | -0.035 | 0.838 |
| Income/Loss From Continuing Operations Before Tax |
25.90%
-8.221
|
-11.10 | -8.435 | -9.614 | -8.795 |
| Income/Loss From Continuing Operations After Tax |
25.90%
-8.221
|
-11.10 | -8.435 | -9.614 | -8.795 |
|
Net Income/Loss
|
25.90%
-8.221
|
-11.10 | -8.435 | -9.614 | -8.795 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
188.53K%
29.20
|
0.0155 | 28.92 | 28.92 | 28.92 |
| Diluted Average Shares |
188.53K%
29.20
|
0.0155 | 28.92 | 28.92 | 28.92 |
| Basic Earnings Per Share |
26.32%
-0.28
|
-0.38 | -0.29 | -0.33 | -0.30 |
| Diluted Earnings Per Share |
26.32%
-0.28
|
-0.38 | -0.29 | -0.33 | -0.30 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):